CNTX · Context Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Lehr Martin A. Chief Executive Officer | ▲ Buy | Open Market | 920,190 Shares held | 6/9/2025 | View profile |
| Dick Evan G. SVP of R&D | ▼ Sell | Other | 87,139 Shares held | 10/22/2021 | View profile |
| Minai-Azary Jennifer Lynn Chief Financial Officer | ▲ Buy | Open Market | 80,010 Shares held | 6/6/2025 | View profile |
| Levit Alex C. Chief Legal Officer, Corp. Sec | ▲ Buy | Open Market | 29,000 Shares held | 6/6/2025 | View profile |
| Sahmoud Tarek Chief Medical Officer | ▲ Buy | Open Market | 10,000 Shares held | 8/16/2022 | View profile |
Transaction History
| Lehr Martin A. | ▲ Buy | Open Market | 100,000 | $70K | 6/9/2025 |
| Levit Alex C. | ▲ Buy | Open Market | 20,000 | $12K | 6/6/2025 |
| Minai-Azary Jennifer Lynn | ▲ Buy | Open Market | 40,010 | $25K | 6/6/2025 |
| Lehr Martin A. | ▲ Buy | Open Market | 5,823 | $5K | 2/21/2023 |
| Lehr Martin A. | ▲ Buy | Open Market | 5,606 | $5K | 2/13/2023 |
| Lehr Martin A. | ▲ Buy | Open Market | 5,040 | $5K | 2/6/2023 |
| Lehr Martin A. | ▲ Buy | Open Market | 7,027 | $5K | 1/30/2023 |
| Lehr Martin A. | ▲ Buy | Open Market | 6,839 | $5K | 1/23/2023 |
| Lehr Martin A. | ▲ Buy | Open Market | 6,783 | $5K | 1/17/2023 |
| Minai-Azary Jennifer Lynn | ▲ Buy | Open Market | 25,000 | $19K | 12/16/2022 |
| Lehr Martin A. | ▲ Buy | Open Market | 20,000 | $15K | 12/16/2022 |
| Levit Alex C. | ▲ Buy | Open Market | 6,000 | $5K | 12/9/2022 |
| Lehr Martin A. | ▲ Buy | Open Market | 13,000 | $24K | 8/19/2022 |
| Minai-Azary Jennifer Lynn | ▲ Buy | Open Market | 15,000 | $27K | 8/17/2022 |
| Sahmoud Tarek | ▲ Buy | Open Market | 10,000 | $20K | 8/16/2022 |
| Lehr Martin A. | ▲ Buy | Open Market | 13,000 | $42K | 12/16/2021 |
| Levit Alex C. | ▲ Buy | Open Market | 3,000 | $15K | 10/22/2021 |
| Lehr Martin A. | ▲ Buy | Open Market | 10,000 | $50K | 10/22/2021 |
| Lehr Martin A. | ▼ Sell | Other | 52,680 | $376K | 10/22/2021 |
| Lehr Martin A. | ▼ Sell | Other | 210,722 | — | 10/22/2021 |
| Lehr Martin A. | ▼ Sell | Other | 586,476 | — | 10/22/2021 |
| Dick Evan G. | ▼ Sell | Other | 26,587 | — | 10/22/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
CNTX appears on Yahoo's recent strong negative rating lists
Yahoo listed Context Therapeutics in its strong negative rating lists for October 13 and October 15. The inclusion reflects recent analyst concerns about the company's outlook. The stock is currently trading with a low RSI and near its identified support level, which aligns with the negative sentiment.
CNTX appears on Yahoo's recent strong negative rating lists. Yahoo listed Context Therapeutics in its strong negative rating lists for October 13 and October 15. The inclusion reflects recent analyst concerns about the company's outlook. The stock is currently trading with a low RSI and near its identified support level, which aligns with the negative sentiment.